Why Lifehealthcare Group Ltd shares popped 8% today

Asides from average operating results in February, one of the other big factors weighing on Lifehealthcare Group Ltd’s (ASX: LHC) share price recently was the review of the government’s Prosthesis List, which covers the prices that can be charged for prosthetic implants. The media has widely reported that prostheses in Australia are substantially overpriced.

Media speculation was such that Lifehealthcare was forced to announce to the market that the variation between public and private pricing for prostheses that it supplied was approximately 3% – nowhere near the levels reported by the media. Additionally, Lifehealthcare also declared that it did not supply Cardiac Devices, Intra-ocular lenses, and Hips and Knees on a material basis – so this was unlikely to be affected by the review.

The market was not convinced, but investors who were brave enough to buy during the troughs earlier this year have done quite well, potentially up 50% since April:

source: Google Finance

source: Google Finance

Shares in fellow device supplier Paragon Care Ltd. (ASX: PGC) conversely slumped 3% today, although that company doesn’t appear to generate significant revenue from the affected prostheses either.

Even once Lifehealthcare shares rebounded from $1.50 to $1.70, the company was not expensive. Today’s prices reflect the improved cash performance in the second half of the year, although a number of headwinds remain and management has suggested margins could shrink again this year. Overall, today’s price appears to adequately factor in those headwinds.

If you are interested in quality dividend shares, then I would recommend this top dividend share instead. A strong yield and potential share price gains make this a great investment idea in my opinion.

Our Top Dividend Stock for Smart Investors

Our resident dividend expert names his Top Dividend Share. Not only are the shares dirt cheap, the company is trading on a fat fully franked dividend yield. Simply click here to gain access to this comprehensive FREE investment report, including the name of this fast growing ASX dividend share. No credit card required!

Motley Fool contributor Sean O'Neill owns shares of LifeHealthcare Group Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.